Abstract
Resistance to antiplatelet therapy is the recent phenomenom with potential clinical influence. We can define resistance to antiplatelet therapy clinically or laboratory.
Etiology of resistance to antiplatelet therapy is complex. The percentage of ASA non-responders fluctuates from 5 to 45% depending on the methods used.